Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/28/2026 | Q4 | $1.3B | -- | -- | $4.73 | -- |
| 10/22/2025 | Q3 | $1.5B | $1.4B | $6.98 | $6.84 | $0.14 |
| 07/23/2025 | Q2 | $1.5B | $1.5B | $7.82 | $6.87 | $0.95 |
| 04/23/2025 | Q1 | $1B | $1.1B | $3.37 | $3.25 | $0.12 |
| 01/29/2025 | Q4 | $1.2B | $1.3B | $5.52 | $4.24 | $1.28 |
| 10/23/2024 | Q3 | $1.4B | $1.5B | $6.68 | $6.01 | $0.66 |
| 07/24/2024 | Q2 | $1.5B | $1.5B | $6.87 | $6.57 | $0.30 |
| 04/24/2024 | Q1 | $1.1B | $1B | $3.47 | $3.16 | $0.32 |
| 01/31/2024 | Q4 | $1.1B | $1.2B | $4.04 | $3.43 | $0.60 |
| 10/26/2023 | Q3 | $1.3B | $1.4B | $3.65 | $4.71 | -$1.06 |
| 07/27/2023 | Q2 | -- | $1.4B | $6.10 | -- | -- |
| 04/27/2023 | Q1 | -- | $1B | $2.75 | -- | -- |
| 01/31/2023 | Q4 | -- | $1.1B | $2.65 | -- | -- |
| 10/27/2022 | Q3 | -- | $1.2B | $4.00 | -- | -- |
| 07/28/2022 | Q2 | -- | $1.4B | $4.96 | -- | -- |
| 04/25/2022 | Q1 | -- | $1B | $2.29 | -- | -- |
| 02/01/2022 | Q4 | -- | $964.8M | $2.27 | -- | -- |
| 10/25/2021 | Q3 | -- | $1.1B | $3.41 | -- | -- |
| 07/26/2021 | Q2 | -- | $1.2B | $4.51 | -- | -- |
| 04/26/2021 | Q1 | -- | $930.5M | $2.20 | -- | -- |
| 02/02/2021 | Q4 | -- | $914M | $2.89 | -- | -- |
| 10/19/2020 | Q3 | -- | $1.1B | $3.41 | -- | -- |
| 07/20/2020 | Q2 | -- | $941.3M | $2.60 | -- | -- |
| 04/20/2020 | Q1 | -- | $723.8M | $0.33 | -- | -- |
| 02/04/2020 | Q4 | -- | $885M | $2.93 | -- | -- |
| 10/21/2019 | Q3 | -- | $1B | $2.94 | -- | -- |
| 07/22/2019 | Q2 | -- | $1.1B | $2.80 | -- | -- |
| 04/22/2019 | Q1 | -- | $790.3M | $1.73 | -- | -- |
| 02/05/2019 | Q4 | -- | $843.6M | $1.87 | -- | -- |
| 10/22/2018 | Q3 | -- | $1B | $2.65 | -- | -- |
| 07/23/2018 | Q2 | -- | $1.2B | $3.35 | -- | -- |
| 04/23/2018 | Q1 | -- | $834.8M | $0.90 | -- | -- |
| 02/06/2018 | Q4 | -- | $891.8M | $1.01 | -- | -- |
| 10/23/2017 | Q3 | -- | $1.1B | $2.44 | -- | -- |
| 07/24/2017 | Q2 | -- | $1.1B | $2.69 | -- | -- |
| 04/24/2017 | Q1 | -- | $793.4M | $1.00 | -- | -- |
| 02/07/2017 | Q4 | -- | $897.3M | $0.93 | -- | -- |
| 10/17/2016 | Q3 | -- | $1B | $2.33 | -- | -- |
| 07/18/2016 | Q2 | -- | $1B | $2.51 | -- | -- |
| 04/18/2016 | Q1 | -- | $715.2M | $0.56 | -- | -- |
| 02/08/2016 | Q4 | -- | $834.1M | $0.25 | -- | -- |
Lennox International, Inc. reported $1.4B worth of top line sales in its most recent quarter.
Lennox International, Inc. announced earnings per share of $6.98 which represents a beat of analyst forecast a $6.84 per share.
Lennox International, Inc. reported $468.6M that represents $13.31 per share over the last quarter.
Lennox International, Inc.'s earnings are forecast to grow from $22.54 per share to $21.20 per share next year representing an increase of 1.64%.
Lennox International, Inc.'s next earnings date is January 28, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.